The decline of venture capital investments in life sciences startups has provoked a lot of angst in the U.S., with many experts predicting a shortage of new drugs for the pharmaceutical product pipeline. Life sciences startups typically require hundreds of millions of dollars before they can show that an experimental drug might work in clinical … Continue reading “Using Frugal Business Model, Orphagen Targets Orphan Receptors”
Author: Juliet Preston
A New Age in Aerospace & Other Takeaways from the Rock Stars Summit
As the editor in chief of Wired magazine for a dozen years, Chris Anderson was in the enviable position of seeing over the horizon and anticipating how innovation is changing our lives. So would you take heed if Anderson said an industrial revolution is imminent in aerospace innovation? Indeed, more than 200 people were spellbound … Continue reading “A New Age in Aerospace & Other Takeaways from the Rock Stars Summit”
J&J Creates Space at Janssen Labs for Life Sciences Entrepreneurs
Johnson & Johnson’s innovation center, Janssen Labs, has admitted 18 early stage companies since opening its “no strings attached” business accelerator program in San Diego a year ago. Now the incubator is opening its doors to solo entrepreneurs as well. In a statement today, Janssen Research & Development says it is making room at Janssen … Continue reading “J&J Creates Space at Janssen Labs for Life Sciences Entrepreneurs”
Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target
Experts in nutrition science have long fretted about the correlation between diets that are rich in certain foods—such as red meat and dairy products—with an increased risk of heart attacks, cancer, and other diseases associated with inflammation. Ajit Varki, a UC San Diego professor of molecular and cellular medicine, has identified a potential explanation—from an … Continue reading “Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target”